Endoscopic Ablation Therapy: Imaging and Advanced Technology in Action

Gastroenterology

Volumn 137, Issue 4, 2009, Pages 1225-1228

  Wolfsen, Herbert C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; OMEPRAZOLE; PHOTOFRIN;

ARTICLE; BARRETT ESOPHAGUS; BILE DUCT CARCINOMA; CATHETER ABLATION; CRYOTHERAPY; ELECTROCOAGULATION; ENDOSCOPIC ABLATION THERAPY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; ENZYME INHIBITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS STRICTURE; GASTROINTESTINAL ENDOSCOPY; HUMAN; IMAGING AND DISPLAY; IMAGING SYSTEM; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STOMACH ACID; EQUIPMENT DESIGN; ESOPHAGOSCOPE; ESOPHAGOSCOPY; ESOPHAGUS DISEASE; INSTRUMENTATION; METHODOLOGY; PATHOLOGY; PHOTOCHEMOTHERAPY; PREDICTION AND FORECASTING; REVIEW; TREATMENT OUTCOME;

CATHETER ABLATION; CRYOTHERAPY; EQUIPMENT DESIGN; ESOPHAGEAL DISEASES; ESOPHAGOSCOPES; ESOPHAGOSCOPY; HUMANS; PHOTOCHEMOTHERAPY; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 70349428402     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.08.039     Document Type: Article

References (22)

1. Wolfsen H.C. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia. Exp Rev Med Devices 2 (2005) 713-723
2. Sampliner R.E. Prevention of adenocarcinoma by reversing Barrett's esophagus with mucosal ablation. World J Surg 27 (2003) 1026-1029
3. Wolfsen H.C. Endoluminal therapy for Barrett's esophagus. Gastrointest Endosc Clin North Am 17 (2007) 59-82
4. Wolfsen H.C., Crook J.E., Krishna M., et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. Gastroenterology 135 (2008) 24-31
5. Sharma P., Bansal A., Hawes R., et al. Detection of metaplasia (IM) and neoplasia in patients with Barrett's esophagus (BE) using high-definition white light endoscopy (HD-WLE) versus narrow band imaging (NBI): a prospective, multi-center, randomized, crossover trial. (Abstract 945). Gastrointest Endosc 69 (2009) AB135
6. Waxman I., and Konda V.J. Mucosal ablation of Barrett esophagus. Nat Rev Gastroenterol Hepatol 6 (2009) 393-401
7. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 360 (2009) 2277-2288
8. Wolfsen H.C. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J Clin Gastroenterol 39 (2005) 653-664
9. Wolfsen H.C. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. J Clin Gastroenterol 39 (2005) 189-202
10. Prasad G.A., Wang K.K., Baron T.H., et al. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma. Clin Gastroenterol Hepatol 5 (2007) 743-748
11. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
12. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 132 (2007) 1226-1233
13. Prasad G.A., Wu T.T., Wigle D.A., et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology (2009) Jun 12 [Epub ahead of print]
14. Panjehpour M., and Overholt B.F. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia. Lasers Surg Med 38 (2006) 390-395
15. Gill K.R., Wolfsen H.C., Preyer N.W., et al. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia. Clin Cancer Res 15 (2009) 1830-1836
16. Van Vilsteren F., Pouw R., Seewald S., et al. A multi-center randomized trial comparing stepwise radical endoscopic resection versus radiofrequency ablation for Barrett esophagus containing high-grade dysplasia and/or early cancer. (Abstract 939). Gastrointest Endosc 69 (2009) AB133
17. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 68 (2008) 867-876
18. Shaheen N., Greenwald B., Dumot J., et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. (Abstract W1387). Gastrointest Endosc 69 (2009) AB357
19. Greenwald B., Dumot J., Abrams J., et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. (Abstract W1352). Gastrointest Endosc 69 (2009) AB349
20. Canto M., Gorospe E., Shin E., et al. Carbon dioxide cryotherapy is a safe and effective treatment of Barrett's esophagus (BE) with HGD/intramucosal carcinoma. (Abstract W1323). Gastrointest Endosc 69 (2009) AB341
21. Bergman J.J. Radiofrequency ablation-great for some or justified for many?. N Engl J Med 360 (2009) 2353-2355
22. Panjepour M., Overholt B., Phan-Brooks M., et al. Photodynamic therapy (PDT) for Barrett's esophagus with dysplasia: long-term follow-up of gastroesophageal junction area is recommended. (Abstract W1317). Gastrointest Endosc 69 (2009) AB339